REFERENCES
- Barr J., Woodburn K. W., Ng S. Y., Shen H. R., Heller J. Post surgical pain management with poly(ortho esters). Adv Drug Deliv Rev. 2002; 54: 1041–1048, [PUBMED], [INFOTRIEVE], [CSA]
- Bodmer D., Kissel T., Traechslin E. Factors influencing the release of peptides and proteins from biodegradable depot systems. J. Control. Rel. 1992; 21: 129–138, [CSA], [CROSSREF]
- Chandrashekar G., Udupa N. Biodegradable injectable implant system for long term drug delivery using poly(lactic-co-glycolic)acid copolymers. J. Pharm. Pharmacol. 1996; 48: 669–674, [PUBMED], [INFOTRIEVE], [CSA]
- Danckwerts M., Fassihi A. Implantable controlled release drug delivery system: a review. Drug Dev Ind Pharm 1991; 17: 1465–1502, [CSA]
- Hnatyszyn J., Kossovsky N., Gelman A., Sponsler E. Drug delivery systems for the future. J. Parent. Sci. Technol. 1994; 48: 247–254, [CSA]
- Jain R., Shah H. N., Malick W. A., Rhodes C. T. Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches. Drug Dev. Ind. Pharm. 1998; 24: 703–727, [PUBMED], [INFOTRIEVE], [CSA]
- Jeong B., Bae Y. H., Lee D. S., Kim S. W. Biodegradable block copolymers as injectable drug delivery systems. Nature 1997; 388: 860–862, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kamath R., Rao B. S. S., Uma Devi P. Response of a mouse fibrosarcoma to withaferin A and radiation. Pharm. Pharmacol. Commun. 1999; 5: 287–291, [CSA]
- Langer R. New method of drug delivery. Science 1981; 240: 1527–1533, [CSA]
- Langer R., Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976; 263: 797–800, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Naresh R. A., Udupa N., Devi P. U. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice. Indian J. Exp. Biol. 1996; 8: 764–772, [CSA]
- Ogawa Y., Yasmamoto M., Okada H., Yashiki T., Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or poly(lactic/glycolic)acid. Chemical and Pharmaceutical Bulletin 1998; 36: 1502–1507, [CSA]
- Persad R. Leuprorelin acetate in prostate cancer: a European update. Int J Clin Pract. 2002; 56: 389–396, [PUBMED], [INFOTRIEVE], [CSA]
- Ravivarapu H. B., Moyer K. L., Dunn R. L. Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. Int J Pharm. 2000; 194: 181–191, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shah N. H., Railkar A. S., Chen F. C., Tarantino R., Kumar S., Murjani M., Palmer D., Infeld M. H., Malick A. W. A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) and (PLGA) copolymers. J. Control. Rel. 1993; 27: 139–147, [CSA], [CROSSREF]
- Shah S. S., Gha Y., Pitt C. G. Poly(lactic acid-co-DL-lactic acid): diffusion or degradation controlled delivery?. J. Control. Rel. 1992; 18: 261–270, [CSA], [CROSSREF]
- Shenoy D. B., D'Souza R. J., Udupa N. Poly(DL-lactide-co-glycolide) microporous microsphere based depot formulation of a peptide-like antineoplastic agent. J. Microencaps. 2002; 19: 523–535, [CSA], [CROSSREF]
- Shiu G. K., Goehl T. J., Pitlick W. H. Rapid high-performance liquid chromatographic determination of bloemycin A2 in plasma. J. Pharm. Sci. 1979; 68: 232–243, [PUBMED], [INFOTRIEVE], [CSA]
- Singh U. V., Shenoy B. D., Udupa N. Novel carriers in cancer chemotherapy. Advances in Controlled and Novel Drug Delivery, N. K. Jain. Informa UK Ltd, New Delhi 2001; 40–69
- Westphal M., Hilt D. C., Bortey E., Delavault P., Olivares R., Warnke P. C., Whittle I. R., Jaaskelainen J., Ram Z. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol. 2003; 5: 79–88, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zentner G. M., Rathi R., Shih C., McRea J. C., Seo M. H., Oh H., Rhee B. G., Mestecky J., Moldoveanu Z., Morgan M., Weitman S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Rel. 2001; 72: 203–215, [CSA], [CROSSREF]